The Real-Life Effectiveness and Safety of Omalizumab Updosing in Patients With Chronic Spontaneous Urticaria
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Real-Life Effectiveness and Safety of Omalizumab Updosing in Patients With Chronic Spontaneous Urticaria
Authors
Keywords
-
Journal
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
Volume -, Issue -, Pages 120347541984795
Publisher
SAGE Publications
Online
2019-04-29
DOI
10.1177/1203475419847956
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New insights into the utility of omalizumab
- (2019) Juan Carlos Cardet et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
- (2018) T. Zuberbier et al. ALLERGY
- Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria
- (2018) L. Curto-Barredo et al. BRITISH JOURNAL OF DERMATOLOGY
- Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria
- (2018) Murat Türk et al. Journal of Allergy and Clinical Immunology-In Practice
- Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria
- (2018) Matthew D. Straesser et al. Journal of Allergy and Clinical Immunology-In Practice
- Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab
- (2018) Karsten Weller et al. ALLERGY
- Omalizumab Updosing for Better Disease Control in Chronic Spontaneous Urticaria Patients
- (2018) Emek Kocatürk et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria
- (2018) Tessa Niemeyer-van der Kolk et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients
- (2018) A.V. Marzano et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria
- (2018) Michael D. Tharp et al. JAMA Dermatology
- Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety
- (2017) Ana M Giménez-Arnau EXPERT OPINION ON BIOLOGICAL THERAPY
- Responsiveness and minimal important difference of the urticaria control test
- (2017) Tatevik Ohanyan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature
- (2017) Alessandro Tonacci et al. PHARMACOTHERAPY
- Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients
- (2017) Zahava Vadasz et al. Journal of Allergy and Clinical Immunology-In Practice
- Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials
- (2016) Zuo-Tao Zhao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review
- (2016) Joshua J. Clark et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The Turkish Guideline for the Diagnosis and Management of Urticaria-2016
- (2016) Emek Kocatürk Göncü et al. TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY
- Outcomes of using omalizumab for more than 1 year in refractory chronic urticaria
- (2015) Daniel Har et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment
- (2015) M.C. Urgert et al. BRITISH JOURNAL OF DERMATOLOGY
- Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control
- (2014) Karsten Weller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The diagnosis and management of acute and chronic urticaria: 2014 update
- (2014) Jonathan A. Bernstein et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Estimating The Minimal Important Difference (MID) Of The Measures In The Urticaria Patient Daily Diary (UPDD): Updated Findings Using Data From The Asteria I, Asteria II, and Glacial Studies Of Omalizumab In Chronic Idiopathic/Spontaneous Urticaria
- (2014) Susan Mathias et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria
- (2009) S. Takahagi et al. ALLERGY
- How to assess disease activity in patients with chronic urticaria?
- (2008) A. Młynek et al. ALLERGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started